IVF recovery — the inflammation conversation after the protocol ends

Whether the cycle worked or didn't, you've been through something significant. That part tends to get skipped over. The medical system is oriented, reasonably, toward the goal — embryo, pregnancy, live birth — and recovery from the process itself gets bracketed as minor, expected, self-resolving. For most people, eventually, it does resolve. But the timeline and the mechanism deserve more honest explanation than they typically receive.

Here is what an IVF protocol actually asks of the body, and why the recovery arc looks the way it does.

Ovarian stimulation is the foundational intervention: injectable gonadotropins that override the body's own hormonal regulation and push the ovaries to develop ten, fifteen, sometimes twenty or more follicles simultaneously. In a natural cycle, one follicle develops and releases its egg; the rest undergo atresia. Stimulation suspends that selection process and recruits the entire cohort. The ovaries enlarge substantially. Estrogen rises to levels that may be five to ten times higher than the peak of a natural cycle — sometimes higher, depending on the protocol and the response. This hormonal environment is designed. It is also a significant departure from what the body's endocrine system expects to be doing.

Egg retrieval is a surgical procedure. A needle passes through the vaginal wall into each follicle, under ultrasound guidance, to aspirate the fluid and collect the egg. It is typically done under light sedation and takes twenty to forty minutes. Most people tolerate it well. It is still surgery. There is tissue trauma, minor bleeding, the physiological stress response that accompanies any invasive procedure, and the lingering effects of anesthesia. The ovaries, which were already enlarged from stimulation, remain tender afterward. Ovarian hyperstimulation syndrome — ranging from mild bloating and discomfort to the more serious fluid accumulation and vascular complications seen in severe cases — is a recognized risk precisely because stimulation pushes the ovaries well beyond their normal operating range.

After retrieval, if a fresh transfer is planned, the body is managed through the next phase with supplemental hormones — typically progesterone, sometimes estrogen, sometimes both — to support the uterine lining and early implantation. If a frozen embryo transfer follows later, a separate hormonal preparation cycle occurs. Some protocols include prednisone, to modulate immune response at the time of transfer. Some include anticoagulants, particularly if there's a history of recurrent implantation failure or clotting factors. The cumulative hormonal and pharmacological load, from the start of a stimulation cycle through transfer and early pregnancy support or through a negative result, is substantial.

The inflammatory burden of all of this is real and underacknowledged. Stimulation itself elevates cytokines — the signaling molecules that coordinate immune responses and inflammation. Retrieval adds a localized inflammatory event. The hormonal shifts before, during, and after the cycle affect systems well beyond reproduction: the gut, the thyroid, the adrenals, the skin, the nervous system. For women with pre-existing autoimmune conditions — Hashimoto's thyroiditis, eczema, MCAS, lupus, rheumatoid arthritis — the post-cycle period frequently triggers a flare. This is not coincidence. Immune regulation and hormonal state are tightly coupled. Significant hormonal perturbation destabilizes immune regulation. The flare is a predictable downstream effect.

Mood disruption after a cycle — regardless of outcome — is more common and more severe than the clinical literature fully acknowledges. The withdrawal from high-dose exogenous estrogen and progesterone after a negative result mirrors, in some respects, the hormonal cliff of early postpartum: the system was calibrated to an elevated hormonal environment, and then that environment suddenly ended. The emotional weight of a negative result, or the strange suspended state of early pregnancy after a positive, compounds the physiological reality. The grief of a failed cycle is real and is not separate from biology. Grief activates the stress response. Sustained cortisol elevation suppresses immune function, disrupts sleep, and delays the normalization of the HPO axis — the hypothalamic-pituitary-ovarian feedback loop that governs hormonal cycling.

Sleep after a cycle is often fractured. Progesterone has sedating properties, but its withdrawal — or its replacement with synthetic forms that don't carry the same neurosteroid activity as endogenous progesterone — can disrupt sleep architecture. Anxiety, which spikes in the two-week wait and often doesn't dissipate cleanly after a result either way, activates the nervous system in ways that are incompatible with deep sleep. If the cycle resulted in pregnancy, the first trimester brings its own sleep disruptions. If it didn't, the grief and recalibration do.

Gut symptoms are common in this period as well — bloating, altered motility, and food sensitivities that surface as the hormonal shifts ripple through a digestive system densely populated with hormone receptors and immune tissue.

None of this means something has gone wrong. It means the body has been through a genuine physiological event and is resetting several systems at once. The most useful framing for recovery is patience paired with foundational support — protein, protected sleep, a lower inflammatory load, gentle movement, and space for the emotional weight — with any adjunctive tools like NAD+, glutathione, or BPC-157 considered only after the active cycle ends, never during stimulation, pregnancy, or breastfeeding, and always within a full evaluation by your prescribing provider. Given the timeline its own physiology implies, recovery may be worth treating as a real phase of the process rather than an afterthought to it.